RAIN

Rain Therapeutics to Report Second Quarter 2022 Financial Results and Highlights of Recent Progress on August 4, 2022

CGEN

Compugen - Compugen Second Quarter 2022 Financial Results and Corporate Update

CGEN

Compugen - Addressing Immunotherapy Resistance Through PVRIG And TIGIT Blockade

MRTX

Mirati Therapeutics Inc. - Q2 2022 Earnings Call & Webcast